Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial

Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-03T21:21:51.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.9%
    Check dated 2026-10-20T21:56:58.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-06T22:03:47.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) was added to the Record History and the previous revision (v3.6.6) was removed, updating the listing of the study record versions.
    Difference
    0.1%
    Check dated 2026-09-15T20:55:03.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.6) appears in the study's record history, reflecting a metadata update to the record. This update does not alter the study data or the information presented to users.
    Difference
    0.1%
    Check dated 2026-09-01T19:15:09.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    The history now shows a new revision labeled v3.6.5, replacing the previous v3.6.4. This indicates an internal update to the page version rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-11T08:23:22.000Z thumbnail image

Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.